Catalyst Wire Dossier Catalyst Wire Dossier

CELBESTA

· Dong-A ST Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CELBESTA, covering 2020-02-05 to 2020-02-05. Get the full timeline:

Most recent: Clinical Trial Update: Study to Compare the Efficacy and Safety of CELBESTA® and CELEBREX® in Patients With Rheumatoid Arthritis [Phase 4]

See pricing